| Field | Specification |
|---|---|
| Mfr No | |
| Concentration | |
| Form | liquid |
| Product Type | |
| Shipping | |
| Storage |
Overview
Streptavidin Quantum Dots are a group of streptavidin conjugated, water soluble core/shell quantum dots. Streptavidin is covalently coupled to the surface of quantum dots and makes most of the biotin binding sites sterically available for binding of biotinylated molecules such as protein, DNA and peptide. It's highly recommended that the monobiotinylated molecules which have only one biotin linked to each biomolecule, is used to link to Streptavidin Quantum Dots. Otherwise,Streptavidin Quantum Dots tends to aggregate.
Key Features
- Narrow emission peak
- Wide choice of emission colors
- Low non-specific binding
- High colloidal stability
Applications
- Immunoassay
- Multiplexing
- Tissue Imaging
Physical & Chemical Properties
- Zeta Potential: from -25 mV to -40mV
- Water Solubility: Completely miscible
- Emission Range: 425 nm-620 nm
- Full Width at Half Maximum (FWHM): < 35 nm
- Reaction Group: streptavidin
- Chemical Stability: Stable under recommended storage conditions.
- Incompatible Materials: Strong oxidizing agents
- Appearance / Color: green to red
Streptavidin Quantum Dots are core/shell quantum dots (emission 425–620 nm) with streptavidin conjugated to their surface. They capture any biotinylated molecule with high affinity (biotin–streptavidin Kd ≈ 10⁻¹⁵ M), providing a bright, photostable fluorescent signal without requiring a secondary antibody or additional amplification steps.
Applications include multiplexed immunoassay (lateral flow, ELISA, bead-based assay), fluorescent tissue section imaging using biotinylated primary antibodies or secondary detection, single-molecule detection, and FRET-based biosensor development.
Streptavidin QDs offer far superior photostability (no photobleaching over time-lapse imaging), narrower emission peaks enabling multiplex detection, and higher molar brightness compared to standard organic dye conjugates. However, the larger particle size (~10–20 nm total diameter including coating) may reduce signal in steric-sensitive applications.
Available in 425, 525, 540, 560, 580, 600, and 620 nm, plus a combo pack. All wavelengths share the same streptavidin surface and can be multiplexed with single-wavelength excitation.
Store at 2–8°C; do not freeze. Protect from prolonged light exposure between uses. Refer to the specification sheet for detailed shelf-life guidance.
The following customization and add-on services are available for this product through the supplier. For inquiries and pricing, contact support@biohippo.com.
Customization Options
- Custom Emission Wavelengths: Additional emission wavelengths beyond the standard catalog range may be available upon request for specialized optical setups.
- Custom Surface Functionalization: Quantum dots with non-standard surface groups (e.g., PEG with specific functional end groups, custom polymer coatings, or alternative reactive groups) can be manufactured for specialized bioconjugation strategies.
- Custom Conjugation Service: Pre-conjugated quantum dot–antibody, quantum dot–streptavidin, or quantum dot–protein conjugates can be prepared using your supplied antibody or ligand. The supplier specializes in conjugation chemistry across quantum dot, iron oxide nanoparticle, magnetic, and latex bead platforms.
- Assay Development: Support for quantum dot-based immunoassay development including lateral flow fluorescent immunoassay and multiplexed QD-based immunoassay platforms is available.
- Bulk & OEM Manufacturing: OEM lateral flow fluorescent bead manufacturing with quantum dot labels for in vitro diagnostic device development is available at scale.
To inquire about customization options, request a quote, or discuss OEM manufacturing, contact support@biohippo.com.
- Dai L et al. (2026). Push-Button Microfluidic Platform with Dual-Signal Nanoprobes for Enhanced Sensitivity Detection of Healthcare-Associated Infection Pathogens at Point-of-Care. Anal Chem. DOI: 10.1021/acs.analchem.5c05437 PMID: 41661240
- Somnet K et al. (2026). Synergistic MIP-aptamer dual-recognition on silver-decorated sulfur-doped graphene quantum dots (S-GQDs@Ag) nanohybrids for ultra-sensitive impedimetric carcinoembryonic antigen detection. Talanta. DOI: 10.1016/j.talanta.2026.129828 PMID: 41990548
- Vashani D et al. (2026). Precursor-dependent optical and structural properties of eleven NIR-emissive graphene quantum dots for bioimaging applications. 2d Mater. DOI: 10.1088/2053-1583/ae4e41 PMID: 41852598
- Amiri Z et al. (2025). Quantum dot-infused nanocomposites: revolutionizing diagnostic sensitivity. Nanoscale. DOI: 10.1039/d5nr00440c PMID: 40735875
- Zhang L et al. (2024). Highly Sensitive, Stable InP Quantum Dot Fluorescent Probes for Quantitative Immunoassay Through Nanostructure Tailoring and Biotin-Streptavidin Coupling. Inorg Chem. DOI: 10.1021/acs.inorgchem.3c04153 PMID: 38395777
- Haque M et al. (2024). Formation of CdTe core and CdTe@ZnTe core-shell quantum dots via hydrothermal approach using dual capping agents: deciphering the food dye sensing and protein binding applications. Phys Chem Chem Phys. DOI: 10.1039/d4cp02225d PMID: 39171443
- Ge W et al. (2025). Self-Calibrated Identification of Metastatic Lymph Nodes Using Full-NIR-II Tunable Ag(2)Se Quantum Dots Engineered by Short-Chain Phosphines. Small. DOI: 10.1002/smll.202510056 PMID: 41147048